SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Enterprises strengthens on unveiling Polycrol+Xtra Strong

05 Mar 2013 Evaluate

Piramal Enterprises is currently trading at Rs. 567.70, up by 14.55 points or 2.63% from its previous closing of Rs. 553.15 on the BSE.

The scrip opened at Rs. 558.90 and has touched a high and low of Rs. 567.90 and Rs. 555.00 respectively. So far 3828 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 617.80 on 11-Dec-2012 and a 52 week low of Rs. 395.00 on 06-Nov-2012.

Last one week high and low of the scrip stood at Rs. 575.00 and Rs. 543.05 respectively. The current market cap of the company is Rs. 9732.56 crore.

The promoters holding in the company stood at 52.99% while Institutions and Non-Institutions held 28.30% and 18.71% respectively.

Piramal Enterprises’ consumer products division has launched ‘Polycrol+Xtra Strong’ under its OTC segment. Polycrol+ is an antacid that is scientifically proven to provide extra strong action against acidity in just five seconds. The brand ambassador chosen for Polycrol+ is five-time World Champion and Olympic medallist & Padma Bhushan recipient MC Mary Kom.

Polycrol + is available in 450ml for Rs 145.00, 170ml for Rs 89.90 and 60ml for Rs 25. The USPs of the product that set it apart includes its unique portable transparent bottle with an informative pack label that helps consumers understand how it works in the stomach.

Piramal Healthcare, formerly known as Nicholas Piramal, is one of the largest pharmaceutical companies in India. Being part of Piramal Group, its healthcare division contributes 50% to group’s revenue.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: